Monthly Archives: February 2024

Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators 

Three Collaborators Selected to Present Positive Nonclinical Data on Genprex Oncology Program at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Read More

Genprex to Present at Upcoming BIO CEO & Investor Conference

Presentation to Highlight Company’s Gene Therapies for Cancer and Diabetes

Read More